Hilliard Lyons has published a research report on Tempur-Pedic TPX and has upgraded the company from Neutral to Long-term Buy. after the company released 1Q earnings.
In the report, Hilliard Lyons writes, "With the shares having fallen ~10% below the five-year median multiples of EV/EBITDA and forward P/E, we believe the intermediate-term risk/reward balance is again reasonable. As such, we are increasing our rating on TPX from Neutral to Long-term Buy with a target price of $70. That price values the shares at 17.1x FY'13E earnings and 9.7x EV / FY'13E EBITDA, multiples that are in line with five-year medians and which we believe is reasonable given the company's financial performance and outlook."
Hilliard Lyons has also established a $70 price target on Tempur-Pedic, which is currently trading down $3.71 from yesterday's $61.34 closing price.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in